Showing 621 - 640 results of 101,661 for search '(( 5 mg decrease ) OR ( 5 ((we decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.46s Refine Results
  1. 621

    LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity. by Xiaobing Ye (49295)

    Published 2015
    “…(A) and (C): EMSA photographs show that LPS-induced decrease in Sp1 DNA binding activity is associated with an increased NF-κB binding activity.…”
  2. 622
  3. 623
  4. 624

    Fig 5 - by Sana Khalid (132742)

    Published 2023
    Subjects:
  5. 625
  6. 626
  7. 627
  8. 628
  9. 629
  10. 630
  11. 631

    DataSheet_1_Hepatic-Specific Decrease in the Expression of Selenoenzymes and Factors Essential for Selenium Processing After Endotoxemia.docx by Laura G. Sherlock (9602411)

    Published 2020
    “…</p>Methods<p>Wild type (WT) adult male C57/B6 mice were exposed to LPS (5 mg/kg, intraperitoneal). Blood, liver, lung, kidney and spleen were collected from control mice as well as 2, 4, 8, and 24 h after LPS. …”
  12. 632
  13. 633
  14. 634

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on pre-specified atherosclerotic traits. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds Ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on primary atherosclerotic traits for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  15. 635
  16. 636
  17. 637

    The NK1-receptor antagonist ezlopitant significantly decreases voluntary intake of sucrose using the drinking in the dark model in mice. by Pia Steensland (362091)

    Published 2013
    “…<p>The highest dose of ezlopitant (15 mg/kg) decreased consumption of 5% sucrose (<b>A</b>). …”
  18. 638
  19. 639
  20. 640